Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
3.1. Market Snippet by Therapy
3.2. Market Snippet by End User
3.3. Market Snippet by Region
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing awareness regarding nasopharyngeal cancer
4.1.1.2. Advancement in technology
4.1.2. Restraints:
4.1.2.1. High treatment cost of nasopharyngeal cancer
4.1.3. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Value Chain Analysis
5.4. PEST Analysis
5.5. Pricing Analysis
5.6. Regulatory Analysis
5.7. Reimbursement Analysis
5.8. Unmet Needs
5.9. Patent Trends
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Therapy
7.1. Introduction
7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapy Segment
7.3. Market Attractiveness Index, By Therapy Segment
7.3.1. Chemotherpy*
7.3.1.1. Introduction
7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
7.3.2. Immunotherapy
7.3.3. Radiation therapy
7.3.4. Others
8. By End User
8.1. Introduction
8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
8.3. Market Attractiveness Index, By End User Segment
8.3.1. Hospitals & Clinics*
8.3.1.1. Introduction
8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
8.3.2. Ambulatory surgery centers Electronic
8.3.3. Others
9. By Region
9.1. Introduction
9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
9.3. Market Attractiveness Index, By Region
9.4. North America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapy
9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.4.5.1. U.S.
9.4.5.2. Canada
9.4.5.3. Mexico
9.5. Europe
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapy
9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.5.5.1. Germany
9.5.5.2. U.K.
9.5.5.3. France
9.5.5.4. Italy
9.5.5.5. Spain
9.5.5.6. Rest of Europe
9.6. South America
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapy
9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.6.5.1. Brazil
9.6.5.2. Argentina
9.6.5.3. Rest of South America
9.7. Asia Pacific
9.7.1. Introduction
9.7.2. Key Region-Specific Dynamics
9.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapy
9.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
9.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.7.5.1. China
9.7.5.2. India
9.7.5.3. Japan
9.7.5.4. Australia
9.7.5.5. Rest of Asia Pacific
9.8. Middle East and Africa
9.8.1. Introduction
9.8.2. Key Region-Specific Dynamics
9.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapy
9.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
9.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Nasopharyngeal Cancer Market- Company Profiles
11.1. Bristol-Myers Squibb Co.*
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Key Highlights
11.1.4. Financial Overview
11.2. Biodiem Ltd.
11.3. Cyclacel Pharmaceuticals Inc.
11.4. Eli Lilly And Co.
11.5. GlaxoSmithKline Plc.
11.6. Merck & Co., Inc.
11.7. Novartis International AG
11.8. Ono Pharmaceutical Co.,
11.9. SafoniTheravectys SA (List Not Exhaustive)
12. Premium Insights
13. DataM Intelligence
13.1. Appendix
13.2. About Us and Services
13.3. Contact Us